CARBAPENENEMS
- Broadest spectrum of activity of all classes
- Imipenem has slightly better gm + activity; lowers seizure threshold
- Meropenem has slightly better gm - activity
- Ertapenem does not cover Pseudomonas
- Doripenem has the most activity against Pseudomonas
- May use in PCN allergic patients (cross reactivity lower than previously thought)
TIGECYCLINE
- Has broad coverage, but does not cover Pseudomonas
- Bacteriostatic; derivative of tetracycline
- Does NOT require renal dosing
- Higher mortality in VAP than other agents; do not use for intra-abdominal infections (poss higher risk of perforation)
AMIKACIN
- Has antipseudomonal activity
- Used in combination with other agents for MDR (multi-drug resistant) bacteria
- Causes nephrotoxicity and ototoxicity
COLISTIN
- Bacteriocidal against many MDR gram - bacteria
- Not active against Proteus, Provincia, Burkholderia, Neisseria, or Serratia
- Nephrotoxicity and ototoxicity reported
References
1. Lee S. Engel MD. Multidrug-Resistant Gram-Negative Bacteria: Trends, Risk Factors, and Treatments. Emerg Med 41(11):18, 2009.
2. Journal of Antimicrobial Chemotherapy, 2004;Vol 54(6) Pp. 1155-1157